Drug intelligence / Profile preview

betamethasone dipropionate + betamethasone disodium phosphate + lidocaine

Development stage
Unknown
Lead developer
Merck
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intramuscular, Intraarticular, Soft Tissue Injection (periarticular), Topical (possible But Less Common For This Exact Triple Combination)
01

Overview

This drug is a combination of two forms of the corticosteroid betamethasone—betamethasone dipropionate and betamethasone disodium phosphate—with the local anesthetic lidocaine. Betamethasone is a potent synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties, acting primarily by inhibiting multiple inflammatory cytokines and suppressing leukocyte migration. The dipropionate form is typically used for topical or intralesional administration due to its prolonged action, while the disodium phosphate form is water-soluble and suitable for rapid onset via injection. Lidocaine acts as a local anesthetic by blocking voltage-gated sodium channels in neuronal cell membranes, thereby preventing pain signal transmission. This combination may be used in clinical settings where both rapid and sustained anti-inflammatory effects are desired along with immediate pain relief, such as in musculoskeletal injections or certain dermatological procedures[1][2][8].

Brand names
DiprospanCelestone Soluspan
Other names
betamethasone dipropionate + betamethasone disodium phosphate + lidocaine 2%betamethasone dipropionate + betamethasone disodium phosphate-Hospital Alvorada-carpal tunnel syndrome
02

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on betamethasone dipropionate + betamethasone disodium phosphate + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on betamethasone dipropionate + betamethasone disodium phosphate + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call